Citigroup
HCAT icon

Citigroup’s Health Catalyst HCAT Stock Holding History

Citigroup’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-32,000
Closed -$836K – 6398
2022
Q1 		$836K Buy
+32,000
New +$908K ﹤0.01% 3128
2021
Q3 		– Sell
-34,000
Closed -$1.89M – 6008
2021
Q2 		$1.89M Buy
+34,000
New +$1.81M ﹤0.01% 2705

Other funds holding HCAT

FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
CF
CDC Financial Chicago, Illinois $157M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
PVM
Palogic Value Management Dallas, Texas $237M AUM 5.37% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $14.3B AUM 19.8% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Citigroup's HCAT Position: Q1 2026 in Review

Citigroup increased its Health Catalyst (HCAT) stake by 94% in Q1 2026, buying an estimated $2.7K and bringing the position to 2,965 shares worth $3.77K. The position accounts for ﹤0.01% of the portfolio, ranked #5315.

Citigroup first reported a position in HCAT in Q3 2019 and has held it in 27 quarters since. The position peaked at $983K in Q2 2021. 130 funds tracked by Wall St. Rank hold HCAT as of Q1 2026.

  • Citigroup held 2,965 shares of Health Catalyst worth $3.77K as of Q1 2026.
  • Citigroup bought 1,435 Health Catalyst shares in Q1 2026, an estimated $2.7K.
  • Health Catalyst made up ﹤0.01% of Citigroup's portfolio in Q1 2026, its #5315 holding.
  • Citigroup first reported a position in Health Catalyst in Q3 2019 and has held it in 27 quarters since.
  • Citigroup's Health Catalyst position peaked at $983K in Q2 2021.
  • 130 funds tracked by Wall St. Rank held Health Catalyst as of Q1 2026.

Based on Citigroup's 13F filing for Q1 2026, filed 11 May 2026.